“抑制Mitofusin-2通过PERK/ATF4途径和活性氧促进心脏成纤维细胞活化”的更正。

2区生物学 Q1 Biochemistry, Genetics and Molecular Biology

Oxidative Medicine and Cellular Longevity Pub Date : 2025-08-18 eCollection Date: 2025-01-01 DOI:10.1155/omcl/9801041

引用次数: 0

摘要

[这更正了文章DOI: 10.1155/2019/3649808.]

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Corrigendum to "Inhibition of Mitofusin-2 Promotes Cardiac Fibroblast Activation via the PERK/ATF4 Pathway and Reactive Oxygen Species".

查看原文本刊更多论文

Corrigendum to "Inhibition of Mitofusin-2 Promotes Cardiac Fibroblast Activation via the PERK/ATF4 Pathway and Reactive Oxygen Species".

[This corrects the article DOI: 10.1155/2019/3649808.].

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Oxidative Medicine and Cellular Longevity 生物-细胞生物学

CiteScore

13.20

自引率

0.00%

发文量

1274

审稿时长

3-8 weeks

期刊介绍： Oxidative Medicine and Cellular Longevity is a unique peer-reviewed, Open Access journal that publishes original research and review articles dealing with the cellular and molecular mechanisms of oxidative stress in the nervous system and related organ systems in relation to aging, immune function, vascular biology, metabolism, cellular survival and cellular longevity. Oxidative stress impacts almost all acute and chronic progressive disorders and on a cellular basis is intimately linked to aging, cardiovascular disease, cancer, immune function, metabolism and neurodegeneration. The journal fills a significant void in today’s scientific literature and serves as an international forum for the scientific community worldwide to translate pioneering “bench to bedside” research into clinical strategies.